Health · 1 sources covering this

STAT+: Pharmalittle: We’re reading about Novo plans to expand its pipeline, early Alkermes ADHD data, and more

Novo Nodisk outlined plans to expand its pipeline and find new products that it could sell more like consumer goods than traditional medicines

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
STAT+: Pharmalittle: We’re reading about Novo plans to expand its pipeline, early Alkermes ADHD data, and more
Novo Nodisk outlined plans to expand its pipeline and find new products that it could sell more like consumer goods than traditional medicines
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/2878bea4edc645c06f32c1391708a08be49f5c6f"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We’re reading about Novo plans to expand its pipeline, early Alkermes ADHD data, and more"></iframe>

STAT+: Pharmalittle: We’re reading about Novo plans to expand its pipeline, early Alkermes ADHD data, and more

How 1 sources are covering this

STAT+: Pharmalittle: We’re reading about Novo plans to expand its pipeline, early Alkermes ADHD data, and more

More from Health

President Trump’s newest vaccine ‘demands’ repeat old misinformation

STAT+: Alkermes’ orexin agonist shows potential to treat ADHD in early-stage trial

STAT+: With new strategy, Novo outlines plans for obesity, direct-to-consumer work

It’s Hard To Predict Who Will Be Suicidal. It’s Easier To Ensure People Can’t Shoot Themselves.

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Pharmalittle: We’re reading about Novo plans to expand its pipeline, early Alkermes ADHD data, and more

More from Health

President Trump&#8217;s newest vaccine &#8216;demands&#8217; repeat old misinformation

STAT+: Alkermes’ orexin agonist shows potential to treat ADHD in early-stage trial

STAT+: With new strategy, Novo outlines plans for obesity, direct-to-consumer work

It’s Hard To Predict Who Will Be Suicidal. It’s Easier To Ensure People Can’t Shoot Themselves.

Reader

Trust & legal

Across the network

President Trump’s newest vaccine ‘demands’ repeat old misinformation